Towercrest Capital Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.45M | Buy |
63,889
+1
| +0% | +$89 | 0.85% | 30 |
|
|
2025
Q4 | $5.05M | Sell |
63,888
-229
| -0.4% | -$18K | 0.8% | 32 |
|
|
2025
Q3 | $5.13M | Buy |
64,117
+59,345
| +1,244% | +$5.06M | 0.82% | 32 |
|
|
2025
Q2 | $434K | Sell |
4,772
-5
| -0.1% | -$456 | 0.08% | 69 |
|
|
2025
Q1 | $448K | Sell |
4,777
-210
| -4% | -$18.8K | 0.09% | 66 |
|
|
2024
Q4 | $453K | Buy |
4,987
+2,101
| +73% | +$200K | 0.07% | 70 |
|
|
2024
Q3 | $300K | Buy |
2,886
+1
| +0% | +$102 | 0.05% | 90 |
|
|
2024
Q2 | $280K | Buy |
2,885
+1
| +0% | +$92 | 0.05% | 94 |
|
|
2024
Q1 | $260K | Sell |
2,884
-552
| -16% | -$46.8K | 0.04% | 93 |
|
|
2023
Q4 | $274K | Buy |
3,436
+8
| +0.2% | +$602 | 0.05% | 89 |
|
|
2023
Q3 | $244K | Buy |
3,428
+1
| +0% | +$75 | 0.05% | 94 |
|
|
2023
Q2 | $264K | Sell |
3,427
-698
| -17% | -$54K | 0.05% | 90 |
|
|
2023
Q1 | $310K | Sell |
4,125
-196
| -5% | -$14.6K | 0.06% | 75 |
|
|
2022
Q4 | $340K | Buy |
4,321
+2
| +0% | +$150 | 0.08% | 69 |
|
|
2022
Q3 | $303K | Buy |
4,319
+2
| +0% | +$157 | 0.07% | 71 |
|
|
2022
Q2 | $346K | Buy |
4,317
+1
| +0% | +$78 | 0.08% | 66 |
|
|
2022
Q1 | $327K | Buy |
4,316
+1
| +0% | +$79 | 0.06% | 74 |
|
|
2021
Q4 | $368K | Buy |
4,315
+923
| +27% | +$72.1K | 0.07% | 71 |
|
|
2021
Q3 | $256K | Buy |
3,392
+2
| +0.1% | +$159 | 0.05% | 84 |
|
|
2021
Q2 | $276K | Sell |
3,390
-440
| -11% | -$36K | 0.05% | 76 |
|
|
2021
Q1 | $302K | Sell |
3,830
-288
| -7% | -$22.6K | 0.06% | 71 |
|
|
2020
Q4 | $352K | Buy |
4,118
+251
| +6% | +$20.8K | 0.08% | 64 |
|
|
2020
Q3 | $298K | Sell |
3,867
-1,499
| -28% | -$114K | 0.07% | 64 |
|
|
2020
Q2 | $393K | Buy |
5,366
+2
| +0% | +$142 | 0.1% | 55 |
|
|
2020
Q1 | $356K | Sell |
5,364
-1,500
| -22% | -$106K | 0.11% | 58 |
|
|
2019
Q4 | $473K | Sell |
6,864
-438
| -6% | -$29.9K | 0.12% | 54 |
|
|
2019
Q3 | $537K | Buy |
7,302
+2
| +0% | +$145 | 0.15% | 51 |
|
|
2019
Q2 | $523K | Buy |
7,300
+1
| +0% | +$71 | 0.15% | 51 |
|
|
2019
Q1 | $500K | Buy |
7,299
+1
| +0% | +$65 | 0.14% | 50 |
|
|
2018
Q4 | $434K | Buy |
7,298
+1
| +0% | +$63 | 0.14% | 51 |
|
|
2018
Q3 | $489K | Hold |
7,297
| – | – | 0.14% | 54 |
|
|
2018
Q2 | $473K | Buy |
+7,297
| New | +$477K | 0.15% | 60 |
|
Other funds holding CL
VCM
DAM
VPM
Towercrest Capital Management's CL Position: Q1 2026 in Review
Towercrest Capital Management increased its Colgate-Palmolive (CL) stake by 0% in Q1 2026, buying an estimated $89 and bringing the position to 63,889 shares worth $5.45M. The position accounts for 0.85% of the portfolio, ranked #30.
Towercrest Capital Management first reported a position in CL in Q2 2018 and has held it in 32 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Towercrest Capital Management held 63,889 shares of Colgate-Palmolive worth $5.45M as of Q1 2026.
- Towercrest Capital Management bought 1 Colgate-Palmolive share in Q1 2026, an estimated $89.
- Colgate-Palmolive made up 0.85% of Towercrest Capital Management's portfolio in Q1 2026, its #30 holding.
- Towercrest Capital Management first reported a position in Colgate-Palmolive in Q2 2018 and has held it in 32 quarters since.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Towercrest Capital Management's 13F filing for Q1 2026, filed 1 May 2026.